Growth Metrics

Mesa Laboratories (MLAB) EBIT Margin (2016 - 2025)

Mesa Laboratories' EBIT Margin history spans 16 years, with the latest figure at 12.25% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 305.0% to 12.25% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.87%, a 10872.0% increase, with the full-year FY2025 number at 0.52%, up 12637.0% from a year prior.
  • EBIT Margin hit 12.25% in Q4 2025 for Mesa Laboratories, up from 7.78% in the prior quarter.
  • Over the last five years, EBIT Margin for MLAB hit a ceiling of 12.25% in Q4 2025 and a floor of 460.55% in Q1 2024.
  • Historically, EBIT Margin has averaged 20.74% across 5 years, with a median of 5.61% in 2024.
  • Biggest five-year swings in EBIT Margin: plummeted -45536bps in 2024 and later skyrocketed 43864bps in 2025.
  • Tracing MLAB's EBIT Margin over 5 years: stood at 4.59% in 2021, then skyrocketed by 236bps to 6.27% in 2022, then crashed by -102bps to 0.13% in 2023, then skyrocketed by 7440bps to 9.2% in 2024, then skyrocketed by 33bps to 12.25% in 2025.
  • Business Quant data shows EBIT Margin for MLAB at 12.25% in Q4 2025, 7.78% in Q3 2025, and 5.15% in Q2 2025.